The University of Kansas Cancer Center Blog
Read up on the latest in cancer care, including cancer prevention, cancer research and innovations in cancer treatment.
Children's Mercy Joins Pediatric Early Phase Clinical Trials Network
Children’s Mercy has been designated a non-core member of the Pediatric Early Phase Clinical Trials Network (PEP-CTN), enhancing their ability to bring the latest leading-edge pediatric cancer clinical trials to our region.
The Next Chapter in Immunotherapy Research
By Joseph McGuirk, DO, director of The University of Kansas Cancer Center’s Hematologic Malignancies and Cellular Therapeutics program
Can You Prevent Pancreatic Cancer?
Pancreatic cancer is a rare and deadly type of cancer with poor survival. It has the 3rd-lowest survival rate of all types of cancer. The American Cancer Society estimates 57,600 people will be diagnosed with pancreatic cancer in 2020. There is no w...
Frequently Asked Questions About Proton Therapy
Soon, adults and children who have cancer will not be forced to travel out of state to receive lifesaving proton therapy. The innovative and highly precise therapy will be provided through The University of Kansas Cancer Center, the region’s only Nat...
Why I Got the COVID-19 Vaccine
Dr. Roy Jensen, director of KU Cancer Center, shares why he got the COVID-19 vaccine.
COVID-19 Vaccine FAQs for Cancer Patients
Patients with cancer are particularly vulnerable to COVID-19 because of the immunocompromising nature of cancer treatments. And while the arrival of vaccines gives us hope, it also leads to confusion among cancer patients. Here, we try to address som...
Kansas Medicaid Program Expands Lung Cancer Screening Coverage
Cancer center members advocated for this lifesaving policy change
11 Common Early Signs of Stomach Cancer
More than 7 in 100,000 people are diagnosed with stomach cancer each year, while 3 in 100,000 die from the disease. About 0.8% of all men and women will be diagnosed with stomach cancer at some point in their life. As of 2017, 116,525 in the United S...
Understanding the Stages of Cervical Cancer
Cervical cancer is one of the most common forms of gynecologic cancers, with 6 in 1,000 women receiving a cervical cancer diagnosis at some point in their lifetime. In 2020, American Cancer Society’s estimates there were an estimated 14,000 new cases...
How to Reduce Your Risk of Cancer
The lifetime likelihood of being diagnosed with cancer is about 40%, according to 2020 data from the American Cancer Society. That number is higher for people with specific risk factors. For example, men are most likely to get prostate cancer, and wo...
Raising Cancer Screening Awareness in the Community
Regular cancer screenings play an important part in your healthcare. Cancer can be easier to treat if it is diagnosed earlier, and screening can identify the disease long before symptoms arise. Yet some individuals and populations are less likely to undergo screenings, leaving them at increased risk for later-stage diagnoses and higher mortality rates.
Reduce Your Cancer Risk with Age-Appropriate Screening
Cancer is the 2nd leading cause of death in the United States, yet up to 1/3 of premature deaths from cancer could possibly be avoided through screening. You may be able to reduce your risk of developing certain forms of cancer with age-appropriate...
Can You Prevent Liver Cancer?
In 2020, the American Cancer Society projects that 42,810 new cases of liver cancer will be diagnosed and approximately 30,160 people will die from the disease. Liver cancer affects more men than women each year. Since 1980, the incidence of liver c...
Active Surveillance in African-American men
In an editorial published in JAMA, radiation oncologist Xinglei Shen, MD, weighs in on a study assessing the effectiveness of active surveillance of African-American men with early-stage prostate cancer.